Successful gene Knock-In with CRISPR/Cas9 mediated by LentiFlash® delivery

Highly purified and concentrated LentiFlash® particles combined with an IDLV show:

• Efficient Knock-In results on human primary T cells (as shown on our poster)
• The preservation of the original cell phenotype, proliferation and viability

These promising results make LentiFlash® a game changing technology for the development of innovative strategy from discovery to clinical applications

TO TAKE A LOOK AT THE POSTER